James Peyer has bought SNSE on 24 days since Feb 2021
Insider at Faeth Therapeutics, Inc.
SEC CIK 0001843594 · Filings on SEC.gov ↗
James Peyer's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
28 filings since Feb 2021, newest first
Sensei Biotherapeutics, Inc.
Insider
Sensei Biotherapeutics, Inc.
10% owner
Sensei Biotherapeutics, Inc.
10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Sensei Biotherapeutics, Inc.
Director and 10% owner
Filings come from SEC EDGAR. Not investment advice.